The independent source for health policy research, polling, and news.
861-880 of 1,325 results
Unwilling to wait for federal action, California Gov. Gavin Newsom says he has a plan that could extract discounts from drugmakers and save the state money — one he hopes other states can join.
For one patient, a three-month supply of insulin is $3,700 in the U.S. versus $600 in Mexico. But is it legal?
Sen. Mike Enzi said he knew of a foundation that would import insulin for patients, but it doesn’t appear to exist.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Just as each person’s journey into addiction is unique, different approaches work for people trying to find their way out. For me, detoxing was nightmarish. And a long-held dream come true.
Health was a featured player in President Donald Trump’s 2019 State of the Union address. The president set goals to bring down prescription drug prices, end the HIV epidemic in the U.S. and cure childhood cancer, among other things. Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Alice Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and, for “extra credit,” provide their favorite health policy stories of the week. Rovner also interviews KHN senior correspondent Phil Galewitz about the current “Bill of the Month” feature.
President Donald Trump and FDA officials have pointed to a surge in generic drug approvals, but a data analysis indicates almost half haven’t reached the market.
The president laid out a series of goals, including lowering prescription prices, pursuing an end to the HIV epidemic and boosting funding for childhood cancers.
The White House and HHS want to eliminate a “shadowy system of kickbacks” in the drug industry pipeline.
WBUR and other media organizations sued Purdue Pharma to force the release of previously redacted information in a case brought by the Massachusetts attorney general.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Congress and President Donald Trump are starting to wrestle with health policy issues, and health is already a key debate point in the early run-up to the 2020 Democratic presidential primaries. Might any major health policy legislation be passed and signed this year? Joanne Kenen of Politico, Anna Edney of Bloomberg News and Kimberly Leonard of The Washington Examiner, along with special guest Tom Miller of the American Enterprise Institute, join KHN’s Julie Rovner to discuss these issues and take questions from a live studio audience.
Key House and Senate committees kick off hearings on drug prices, and patients’ families weigh in with tragic stories.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Emboldened by midterm election results and interest in possible presidential runs, Democrats are advancing a slew of new and old legislative proposals. It’s not yet clear, though, which if any could go the distance.
A radio report on an effort in California to hold doctors responsible when a patient overdoses on opioids. Doctors say it is unfair, but the state medical board defends the new project.
In a unique crackdown on what it sees as “excessive prescribing,” the state medical board is investigating hundreds of doctors whose patients ultimately died of opioid overdoses — whether or not the doctors prescribed the fatal medications.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
A JAMA study looking at county-specific federal data finds that the more opioid-related marketing dollars spent in a county, the higher rates of doctors who prescribed those drugs, and ultimately, more overdose deaths.
Patients are often forced into using brand names because drug formularies favor them over cheaper competitors.
© 2026 KFF